Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-079-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Remarks:
- Direct Peptide Reactivity Assay
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental start date: 14 June 2016; Experimental completion date: 18 June 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- direct peptide reactivity assay (DPRA)
- Justification for non-LLNA method:
- This purpose of thestudy (based on the OECD guideline for the testing of chemicals, In chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA), OECD/OCDE document TG 442C) was to assess the reactivity and sensitizing potential of the test substance.
Test material
- Reference substance name:
- Reaction mass of N-(3-{[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]amino}propyl)-N,N-dimethyldocosan-1-aminium chloride and N-(3-{[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]amino}propyl)-N,N-dimethylicosan-1-aminium chloride
- EC Number:
- 947-079-6
- IUPAC Name:
- Reaction mass of N-(3-{[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]amino}propyl)-N,N-dimethyldocosan-1-aminium chloride and N-(3-{[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]amino}propyl)-N,N-dimethylicosan-1-aminium chloride
- Test material form:
- other: paste
Constituent 1
- Specific details on test material used for the study:
- Sponsor’s identification: Methoxy Cinnamidopropyl Behenyl Dimonium Chloride
Batch No.: INV-1603010
Purity: Solids content, 29.37%
Appearance: Pearly white paste
Expiry/retest date: February 2017
Storage conditions: Room temperature
In chemico test system
- Details on the study design:
- PEPTIDE AND POSITVE CONTROL:
Synthetic peptide containing Cysteine:
Alternative name: Ac-RFAACAA-OH
Batch number: 1556171
Stated purity: 95% (by HPLC)
Molecular Weight: 751.5 g/mol
Supplier: AnaSpec
Storage conditions: Frozen, -20°C
Expiry/retest date: 5 years.
Synthetic peptide containing Lysine:
Alternative name: Ac-RFAAKAA-OH
Batch number: 1556172
Stated purity: 90-95%
Molecular Weight: 776 g/moL
Supplier: AnaSpec
Storage conditions: Frozen, -20°C
Expiry/retest date: 5 years.
Cinnamic Aldehyde (Positive Control):
Batch number: MKBR2427V
Stated purity: >95%
Molecular Weight: 132.16 g/moL
Supplier: SAFC
Storage conditions: Room temperature
Expiry/retest date: February 2019
APPARATUS:
High performance liquid chromatograph (HPLC): Waters Alliance 2695 separation module and 2487 dual wavelength detector
Balances fitted with printers: Capability of weighing to 5 decimal places
General laboratory apparatus and glassware.
ANALYTICAL PROCEDURE:
Reagents:
Acetonitrile (ACN): HPLC gradient grade
Propan-2-ol : HPLC gradient grade
Trifluoroacetic acid (TFA): 99% Pure
Water: Deionised reverse osmosis
Ammonium Acetate: Analytical reagent
Sodium Phosphate, monobasic: Analytical reagent
Sodium Phosphate, dibasic: Analytical reagent
Ammonium Hydroxide: Analytical reagent
100 mM Phosphate buffer, pH 7.5: In house preparation
100 mM Ammonium Acetate buffer, pH 10.2: In house preparation
HPLC Mobile Phase A: 0.1% v/v TFA in Water, in house preparation
HPLC Mobile Phase B: 0.085% v/v TFA in ACN, in house preparation
ASSESSMENT OF TEST ITEM SOLUBILITY:
The solubility of Methoxy Cinnamidopropyl Behenyl Dimonium Chloride in acetonitrile was assessed at a concentration of 100 mM and found to be insoluble. Solubility of the test item at 100 mM was achieved using propan-2-ol as a solvent.
PREPARATION OF PEPTIDE STOCK SOLUTIONS:
Stock solutions of each peptide at concentrations of 0.667 mM were prepared by dissolution of pre-weighed aliquots of the appropriate peptide in ca 20 mL aliquots of the appropriate buffer solution (Cysteine in 100 mM phosphate buffer pH 7.5, Lysine in 100 mM Ammonium acetate buffer pH 10.2).
PREPARATION OF PEPTIDE CALIBRATION STANDARDS:
Calibration standards of both peptides were prepared by diluting the requisite stock solution in the appropriate buffer and acetonitrile and contained each peptide at concentrations of 0.0167 mM, 0.0334 mM, 0.0667 mM, 0.133 mM, 0.267 mM and 0.534 mM. A buffer blank was prepared as well.
PREPARATION OF STABILITY CONTROLS AND PRECISION CONTROLS:
Stability controls and precision controls of both peptides were prepared at a concentration of 0.5 mM in both acetonitrile and propan-2-ol.
PREPARATION OF POSTIVE CONTROL SOLUTION:
The positive control chemical (Cinnamic aldehyde) was prepared at a concentration of 100 mM in acetonitrile.
PREPARATION OF POSITIVE CONTROLS AND CYSTEINE PEPTIDE DEPLETION SAMPLES AND CO-ELUTION CONTROLS:
Propan-2-ol solutions of Methoxy Cinnamidopropyl Behenyl Dimonium Chloride were diluted with the Cysteine peptide to prepare solutions containing 0.5 mM Cysteine and 5 mM of Methoxy Cinnamidopropyl Behenyl Dimonium Chloride. For the co-elution control, buffer solution was used in place of the Cysteine stock solution.
The positive control solutions (prepared in acetonitrile) contained cinnamic aldehyde at a concentration of 5 mM in 0.5 mM Cysteine.
PREPARATION OF POSITIVE CONTROLS AND LYSINE PEPTIDE DEPLETION SAMPLES AND CO-ELUTION CONTROLS:
Propan-2-ol solutions of Methoxy Cinnamidopropyl Behenyl Dimonium Chloride were diluted with the Lysine peptide to prepare solutions containing 0.5 mM Lysine and 25 mM of Methoxy Cinnamidopropyl Behenyl Dimonium Chloride. For the co-elution control, buffer solution was used in place of the Lysine stock solution.
The positive control solutions (prepared in acetonitrile) contained cinnamic aldehyde at a concentration of 25 mM in 0.5 mM Lysine.
INCUBATION:
The appearance of the Methoxy Cinnamidopropyl Behenyl Dimonium Chloride and positive control samples in the HPLC vials was documented after preparation and then the vials placed into the autosampler of the HPLC set at 25°C for a minimum of 22 hours incubation prior to initiation of the analysis run. Just before initiation of the run the appearance of the samples in the vials was assessed and documented again.
ANALYSIS:
The concentration of each respective peptide and the associated peptide positive control was quantified by HPLC using UV detection as detailed in the chromatographic section.
INSTRUMENTAL PARAMETERS:
High performance liquid chromatograph (HPLC): Waters Alliance 2695 separation module and 2487 dual wavelength detector
Column: Agilent Zorbax SB C18, 3.5 µm, 100 x 2.1 mm
Guard column: Phenomenex AJO4286
Column temperature: 30°C
Sample temperature: 25°C
Mobile Phase (MP) A: 0.1% TFA in Water
Mobile Phase (MP) B: 0.085% TFA in ACN
Gradient:
Time (min) MP A (%) MP B (%)
0 90 10
20 75 25
21 10 90
23 10 90
23.5 90 10
30 90 10
Flow rate: 0.35 mL/minute
Stroke volume@ 25 µL
Detector wavelength: UV, 220 nm
Injection volume: 2 µL (slow draw rate)
Run time: 30 minutes
Approximate retention time (Cysteine) 11 minutes
Approximate retention time (Lysine) 7 minutes
CALCULATIONS:
The peak area response for the peptide in each calibration chromatogram was measured. Calibration curves were constructed by linear regression of standard response versus standard concentration. The area responses of the peptide peak observed at the characteristic retention time of each peptide in each sample chromatogram was measured. Peptide depletion was determined using the following equation:
% Peptide depletion = 100 - Peptide peak area in replicate depletion samples (x 100) / Mean Peptide peak area of propan-2-ol control samples.
Results and discussion
- Positive control results:
- Cysteine Peptide Depletion: Positive control mean depletion = 72.5%
Lysine Peptide Depletion: Positive control mean depletion = 57.0%
In vitro / in chemico
Resultsopen allclose all
- Run / experiment:
- mean
- Parameter:
- other: Cysteine peptide depletion (%)
- Value:
- -63
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Run / experiment:
- mean
- Parameter:
- other: Lysine peptide depletion (%)
- Value:
- -0.305
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Parameter:
- other: Overall mean depletion (%)
- Value:
- 0
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: DPRA prediction: negative
- Other effects / acceptance of results:
- Solubility Assessment:
The solubility of the Methoxy Cinnamidopropyl Behenyl Dimonium Chloride in propan-2-ol at a nominal concentration of 100 mM was confirmed.
Acceptance criteria:
All analytical acceptance criteria for each peptide run were met (see overall remarks).
Any other information on results incl. tables
Reactivity Assessment:
The DPRA prediction and the reactivity of Methoxy Cinnamidopropyl Behenyl Dimonium Chloride based on the overall mean and the individual depletion values in the cysteine peptide and the lysine peptide is presented below:
Overall Acheived Depletion Values:
Test item |
Cysteine peptide depletion (%) |
Lysine peptide depletion (%) |
Overall mean depletion (%) |
Reactivity class |
DPRA Prediction |
Methoxy Cinnamidopropyl Behenyl Dimonium Chloride |
n/a |
-0.305 |
0.001 |
No or minimal |
Negative |
1 Reported as zero
Individual Acheived Depletion Values:
Cysteine Peptide Depletion:
Sample |
Peak area (µV.sec) |
Peptide concentration1(µg/ml) |
Peptide Depletion (%) |
Mean Depletion (%) |
CV (%) |
Propan-2-ol Control |
883605 |
374.91 |
1.632 |
1.72 |
0.35 |
879343 |
373.10 |
2.102 |
|||
885366 |
375.66 |
1.432 |
|||
Positive control |
246753 |
104.80 |
72.52 |
72.5 |
1.30 |
244236 |
103.73 |
72.82 |
|||
250620 |
106.44 |
72.12 |
|||
Methoxy Cinnamidopropyl Behenyl Dimonium Chloride |
1434259 |
608.46 |
-62.53 |
-63.0 |
0.40 |
1437686 |
609.92 |
-62.93 |
|||
1445444 |
613.21 |
-63.73 |
CV: Coefficient of Variation
1: Samples prepared at a concentration of 376 µg/ml (0.5 mM)
2: Calculated against a mean reference control peak area of 898220 µV. sec (n=6)
3: Calculated against a mean propan-2-ol control peak area of 882770 µV. sec (n=3)
Lysine Peptide Depletion:
Sample |
Peak area (µV.sec) |
Peptide concentration1(µg/ml) |
Peptide Depletion (%) |
Mean Depletion (%) |
CV (%) |
Propan-2-ol Control |
768421 |
385.02 |
1.262 |
1.09 |
0.26 |
772032 |
386.83 |
0.7932 |
|||
768698 |
385.16 |
1.222 |
|||
Positive control |
333680 |
167.67 |
57.12 |
57.0 |
0.97 |
338525 |
170.10 |
56.52 |
|||
332343 |
167.01 |
57.32 |
|||
Methoxy Cinnamidopropyl Behenyl Dimonium Chloride |
772841 |
387.23 |
-0.4053 |
-0.305 |
0.19 |
772959 |
387.29 |
-0.4213 |
|||
770424 |
386.03 |
-0.09103 |
CV: Coefficient of Variation
1: Samples prepared at a concentration of 388 µg/ml (0.5 mM)
2: Calculated against a mean reference control peak area of 778200 µV. sec (n=6)
3: Calculated against a mean propan-2-ol control peak area of 769720 µV. sec (n=3)
Applicant's summary and conclusion
- Interpretation of results:
- other: no to minimal reactivity
- Remarks:
- potential non-skin sensitiser
- Conclusions:
- Solutions of Methoxy Cinnamidopropyl Behenyl Dimonium Chloride were successfully analysed by the validated DPRA analytical method in both Cysteine and Lysine containing synthetic peptides. The overall result places Methoxy Cinnamidopropyl Behenyl Dimonium Chloride in the no to minimal reactivity class and therefore it is predicted to be a potential non-skin sensitizer.
- Executive summary:
This purpose of the study (based on the OECD guideline for the testing of chemicals, In chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA), OECD/OCDE document TG 442C) was to assess the reactivity and sensitizing potential of Methoxy Cinnamidopropyl Behenyl Dimonium Chloride.
Solutions of Methoxy Cinnamidopropyl Behenyl Dimonium Chloride were successfully analysed by the validated DPRA analytical method in both Cysteine and Lysine containing synthetic peptides. The overall result places Methoxy Cinnamidopropyl Behenyl Dimonium Chloride in the “no or minimal reactivity” class and therefore it is predicted to be a potential non-skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
